Tweet
"Researchers from Oregon Health & Science University School of Medicine in Portland in the US carried out a randomized, double-blind study on 51 adults aged 40 to 70 years who all have SPMS.
A total of 27 participants were randomly assigned to receive 1,200 milligrams of lipoic acid every day for to years, while the remaining 24 were given a placebo.
Whole brain atrophy – which refers to the reduction in total brain volume due to the loss of neurons, considered a marker of MS progression – was assessed at the start of the study, a year in, and at the end using MRI scans.
Lipoic acid outperformed MS drug
The research, published in the journal Neuroimmunology & Neuroinflammation, noted that the reduction of brain atrophy by 68 percent with lipoic acid was greater than the reported impact of the drug ocrelizumab."
http://www.dailymail.co.uk/health/ar...sclerosis.html (july 6,2017)
Has anyone tried it?
A total of 27 participants were randomly assigned to receive 1,200 milligrams of lipoic acid every day for to years, while the remaining 24 were given a placebo.
Whole brain atrophy – which refers to the reduction in total brain volume due to the loss of neurons, considered a marker of MS progression – was assessed at the start of the study, a year in, and at the end using MRI scans.
Lipoic acid outperformed MS drug
The research, published in the journal Neuroimmunology & Neuroinflammation, noted that the reduction of brain atrophy by 68 percent with lipoic acid was greater than the reported impact of the drug ocrelizumab."
http://www.dailymail.co.uk/health/ar...sclerosis.html (july 6,2017)
Has anyone tried it?
Comment